A new cytometric method for the immunophenotypic characterization of bone-derived human osteoclasts

被引:5
作者
Benito, GE
Sánchez, ML
del Pino-Montes, J
Calvo, JJ
Menéndez, P
García-Marcos, MA
Osdoby, P
Orfao, A
机构
[1] Hosp Univ Salamanca, Serv Gen Citometria, Dept Med, Salamanca 37007, Spain
[2] Univ Salamanca, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain
[3] Univ Salamanca, Serv Gen Citometria, E-37008 Salamanca, Spain
[4] Univ Salamanca, Ctr Invest Canc, E-37008 Salamanca, Spain
[5] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain
[6] Washington Univ, Dept Biol, St Louis, MO 63130 USA
来源
CYTOMETRY | 2002年 / 50卷 / 05期
关键词
osteoclast; flow cytometry; human; immunophenotypic; characterization;
D O I
10.1002/cyto.10139
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Osteoclast cell function relates to bone resorption. Isolation and characterization of these cells from in vivo sources remain difficult. The aim of this study was to show the feasibility of using flow cytometry to identify and characterize human mature osteoclasts obtained from bone tissues. Methods: Bone femoral heads obtained as discarded surgical material were used. To check the nature of 121F(+) (a monoclonal antibody specific for human osteoclasts) cells by flow cytometry, we used laser scanning cytometry to analyze simultaneously the immunophenotype and DNA cell content of osteoclast-like cell-enriched bone samples. Results: Results were compared with conventional morphologic and cytochemical studies. The percentage of cells that showed both cytochemical (tartrate-resistant acid phosphatase [TRAP](+)) and immunophenotypic (121F(+)) osteoclast-associated characteristics was very similar (12.5+/-6.2 versus 14.7+/-11.7; P=0.46). Laser scanning cytometry showed that 121F(+) cells were bigger (P=0.04) and they had a higher DNA cell content (P=0.04) and more nuclei per cell (P=0.04) than the 121 V cells present in the same sample. Discussion: This study relied on the combined use of the 121F(+) antibody and different cytometry-based techniques to characterize the osteoclast populations from human bone.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 24 条
[1]  
BARON R, 1999, PRIMER METABOLIC BON, P3
[2]   PITFALLS IN PIT MEASUREMENT [J].
BOYDE, A ;
JONES, SJ .
CALCIFIED TISSUE INTERNATIONAL, 1991, 49 (02) :65-70
[3]   Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: A mechanism involving the osteoclast free radical system [J].
Collin-Osdoby, P ;
Li, L ;
Rothe, L ;
Anderson, F ;
Kirsch, D ;
Oursler, MJ ;
Osdoby, P .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (01) :67-78
[4]  
COLLINOSDOBY P, 1991, J BONE MINER RES, V6, P1353
[5]  
COLLINOSDOBY P, 1995, J BONE MINER RES, V10, P45
[6]  
FLANAGAN AM, 1992, INT J EXP PATHOL, V73, P387
[7]  
Gay CV, 1996, MICROSC RES TECHNIQ, V33, P165, DOI 10.1002/(SICI)1097-0029(19960201)33:2<165::AID-JEMT6>3.0.CO
[8]  
2-S
[9]  
HORTON MA, 1993, J BONE MINER RES, V8, P239
[10]   A human homolog of the 150 kD avian osteoclast membrane antigen related to superoxide dismutase and essential for bone resorption is induced by developmental agents and opposed by estrogen in FLG 29.1 cells [J].
KhalkhaliEllis, Z ;
CollinOsdoby, P ;
Li, L ;
Brandi, ML ;
Osdoby, P .
CALCIFIED TISSUE INTERNATIONAL, 1997, 60 (02) :187-193